Hongyang Lu

Xinyang Normal University — China

Medicine · Health Sciences

22h-index1.4kcitations121works8.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Research Studies(70), Lung Cancer Treatments and Mutations(44), Neuroendocrine Tumor Research Advances(30), Peptidase Inhibition and Analysis(14), Cancer therapeutics and mechanisms(11)

Publications121 total

M2 macrophage-derived exosome nanoplatform for targeted H2S delivery to alleviate hepatic ischemia–reperfusion injury via synergistic anti-oxidative, anti-inflammatory, and anti-ferroptotic effects
Acta Biomaterialia·2025
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive‐stage small‐cell lung cancer: Results of two prospective phase <scp>II</scp> studies
International Journal of Cancer·2025Open Access
Malignant pleural mesothelioma classification and survival prediction with CT imaging using ResNet
European Radiology·2025
Manganese oxide nanozyme-loaded CO-releasing halloysite nanotubes for remodeling colonic immune, microbiota, and intestinal barrier homeostasis with concurrent pain relief in ulcerative colitis
Bioactive Materials·2025· 1 citedOpen Access
EP.13.23 Tislelizumab Plus Sitravatinib or Anlotinib as Maintenance Therapy in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
Journal of Thoracic Oncology·2025
High-Dose Aumolertinib for Untreated <i>EGFR</i>-Variant Non–Small Cell Lung Cancer With Brain Metastases
JAMA Oncology·2025· 5 citedOpen Access
The clinicopathologic characteristics and tumor immune microenvironment of pulmonary enteric adenocarcinoma
Annals of Medicine·2025· 1 citedOpen Access
Predictive value of circulating tumor DNA detection for long-term survival in patients with advanced lung cancer undergoing chemoimmunotherapy.
Journal of Clinical Oncology·2025
Efficacy and safety of HTMC0435 combination with temozolomide in relapsed extensive-stage small-cell lung cancer (ES-SCLC): A phase Ib/II study.
Journal of Clinical Oncology·2025
Coordinated development of digital economy and ecological resilience in China: spatial–temporal evolution and convergence
Environment Development and Sustainability·2025· 12 cited
Clinical outcomes of EGFR-TKI in advanced lung squamous cell carcinoma and EGFR-TKI remodel tumor immune microenvironment
Annals of Medicine·2025· 4 citedOpen Access
Can digital economy narrow the regional economic gap? Evidence from China
Journal of Asian Economics·2025· 26 citedOpen Access
Regional Differences in Agricultural Carbon Emissions in China: Measurement, Decomposition, and Influencing Factors
Land·2025· 34 citedOpen Access
CO‐Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier Integrity
Advanced Science·2025· 9 citedOpen Access
149 Granulomatous Lobular Mastitis due to Corynebacterium kroppenstedtii: Tissue Specificity, Pathogenesis, Microbiologic Workup and Treatment
Laboratory Investigation·2025
The analysis of molecular classification of pulmonary neuroendocrine tumors and relationship between YAP1 and efficacy
Investigational New Drugs·2025· 1 cited
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
The Lancet Oncology·2025· 19 cited
Spatial Dynamic Interaction Effects and Formation Mechanisms of Air Pollution in the Central Plains Urban Agglomeration in China
Atmosphere·2024· 2 citedOpen Access
High-dose almonertinib in treatment-naïve EGFR-mutated NSCLC with CNS metastases: Efficacy and biomarker analysis.
Journal of Clinical Oncology·2024· 1 cited
Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review
Journal of Cancer Research and Clinical Oncology·2024· 6 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Fajun Xie(17), Jing Qin(13), Na Han(11), Zhiyu Huang(7), Ying Fan(6), Lei Gong(5), Chenghui Li(4), Yanjun Xu(4), Jing Qin(4), Qiaoyuan Cheng(4), Yun Fan(3), Weimin Mao(3), Kaiyan Chen(3), Yun Fan(3), Cheng‐Hui Li(3), Zeng Wang(3), Zhiming Jiang(3), Jufen Cai(3), Huang Jie(3), Jiali Gong(3)